Literature DB >> 33692686

Astragali Radix Isoflavones Synergistically Alleviate Cerebral Ischemia and Reperfusion Injury Via Activating Estrogen Receptor-PI3K-Akt Signaling Pathway.

Yong Gu1,2, Xi Chen3,2, Shuping Fu2, Wenlan Liu4, Qi Wang5, Ke-Jian Liu4, Jiangang Shen2,6.   

Abstract

Isoflavones are major neuroprotective components of a medicinal herb Astragali Radix, against cerebral ischemia-reperfusion injury but the mechanisms of neuroprotection remain unclear. Calycosin and formononetin are two major AR isoflavones while daidzein is the metabolite of formononetin after absorption. Herein, we aim to investigate the synergistic neuroprotective effects of those isoflavones of Astragali Radix against cerebral ischemia-reperfusion injury. Calycosin, formononetin and daidzein were organized with different combinations whose effects observed in both in vitro and in vivo experimental models. In the in vitro study, primary cultured neurons were subjected to oxygen-glucose deprivation plus reoxygenation (OGD/RO) or l-glutamate treatment. In the in vivo study, rats were subjected to middle cerebral artery occlusion to induce cerebral ischemia and reperfusion. All three isoflavones pre-treatment alone decreased brain infarct volume and improved neurological deficits in rats, and dose-dependently attenuated neural death induced by l-glutamate treatment and OGD/RO in cultured neurons. Interestingly, the combined formulas of those isoflavones revealed synergistically activated estrogen receptor (estrogen receptors)-PI3K-Akt signaling pathway. Using ER antagonist and phosphatidylinositol 3-kinase (PI3K) inhibitor blocked the neuroprotective effects of those isoflavones. In conclusion, isoflavones could synergistically alleviate cerebral ischemia-reperfusion injury via activating ER-PI3K-Akt pathway.
Copyright © 2021 Gu, Chen, Fu, Liu, Wang, Liu and Shen.

Entities:  

Keywords:  astragali radix; estrogen receptor; isoflavones; neuroprotection; synergism

Year:  2021        PMID: 33692686      PMCID: PMC7937971          DOI: 10.3389/fphar.2021.533028

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  5 in total

Review 1.  Focusing on Formononetin: Recent Perspectives for its Neuroprotective Potentials.

Authors:  Jiao Tian; Xing-Qin Wang; Zhen Tian
Journal:  Front Pharmacol       Date:  2022-05-30       Impact factor: 5.988

2.  A Novel Formononetin Derivative Promotes Anti-ischemic Effects on Acute Ischemic Injury in Mice.

Authors:  Lin Zhao; Jing Han; Jiaqi Liu; Kechen Fan; Tianjie Yuan; Ju Han; Liangliang Chen; Sen Zhang; Ming Zhao; Jinao Duan
Journal:  Front Microbiol       Date:  2021-12-14       Impact factor: 5.640

3.  In Vitro and In Vivo Wound Healing Activity of Astragalus floccosus Boiss. (Fabaceae).

Authors:  Fatemeh Akbari; Mohammad Azadbakht; Ali Bagheri; Lale Vahedi
Journal:  Adv Pharmacol Pharm Sci       Date:  2022-03-29

4.  In Silico, In Vitro, and In Vivo Wound Healing Activity of Astragalus microcephalus Willd.

Authors:  Fatemeh Akbari; Mohammad Azadbakht; Ali Bagheri; Lale Vahedi
Journal:  Adv Pharmacol Pharm Sci       Date:  2022-10-04

5.  Astragalus mongholicus Bunge Water Extract Exhibits Anti-inflammatory Effects in Human Neutrophils and Alleviates Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice.

Authors:  Wei-Jen Cheng; Chih-Chao Chiang; Cheng-Yu Lin; Yu-Li Chen; Yann-Lii Leu; Jia-Yu Sie; Wen-Ling Chen; Chung-Yuan Hsu; Jong-Jen Kuo; Tsong-Long Hwang
Journal:  Front Pharmacol       Date:  2021-12-10       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.